The Food and Drug Administration today recommended strategies for health care providers to conserve prefilled 0.9% sodium chloride intravenous lock/flush syringes, which are in short supply due to increased demand during the COVID-19 public health emergency and recent vendor supply chain challenges. The agency said it is working with manufacturers to help mitigate the shortage.

Related News Articles

Headline
The Department of Health and Human Services has launched a webpage to help health care providers and families locate infant formula during the current national…
Headline
President Biden yesterday invoked the Defense Production Act to ensure manufacturers have the necessary ingredients to make infant formula in the United States…
Headline
The House Energy and Commerce Health Subcommittee today passed, as amended, the Restoring Hope for Mental Health and Well-being Act (H.R. 7666),…
Headline
In a letter today, AHA asked GE Healthcare to provide additional information to help member hospitals manage the current shortage of GE intraveneous…
Headline
The House Energy and Commerce Health Subcommittee yesterday voted unanimously to advance to the full committee the Restoring Hope for Mental Health and Well-…
Headline
The Food and Drug Administration is reporting shortages of GE Healthcare’s iohexol and iodixanol intraveneous contrast media products for computed…